Pulmonx Earnings Estimates, EPS & Revenue | NASDAQ:LUNG

Comments

Pulmonx Corp Earnings Estimates

LUNGNASDAQ

Trade with Public

$1.37

0.010.74%

At close: Apr 9, 5:00 PM EST

$1.37

0.010.74%

Pre-Market: 4:00 AM EST

Overview NewsEarningsOptions Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Pulmonx Earnings Estimates, EPS & Revenue | NASDAQ:LUNG

Pulmonx (LUNG) is scheduled to report Q1 earnings on April 29, 2026. Analysts estimate EPS of $-0.33 and quarterly revenue of $20.29M.

In the most recent quarter (Q4), Pulmonx reported EPS of $-0.25, beating estimates of $-0.39 by 0.36%. Revenue came in at $22.60M, exceeding the estimate of $21.73M by 0.04%.

Pulmonx has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, Pulmonx has averaged an EPS surprise of 0.17% and a revenue surprise of 0.03%.

Earnings Date

Apr 29

EPS Estimate

$-0.330

Quarterly Revenue Estimate

$20.29M

Annual Revenue
(as of Dec 31)

$90.50M

Pulmonx Earnings History

Analyze the earnings history of Pulmonx using advanced sorting and filters.

Loading calendar...

Pulmonx (LUNG) Earnings Per Share

The chart below shows Pulmonx's reported EPS compared to analyst estimates over recent quarters.

Pulmonx (LUNG) Revenue

The chart below shows Pulmonx's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Pulmonx (NASDAQ:LUNG) reporting earnings?

Pulmonx (LUNG) is scheduled to report earnings on April 29, 2026. The last reported earnings were for reported on March 4, 2026 for Q4.

What were the latest earnings per share (EPS) for Pulmonx (NASDAQ:LUNG)?

The Actual EPS was $-0.25, which beat the estimate of $-0.39.

What were Pulmonx’s (NASDAQ:LUNG) revenues?

The Actual Revenue was $22.60M, which beat the estimate of $21.73M.

People Also Watch

Precision Optics Corp Inc

Baird Medical Investment Holdings Ltd

NASDAQ:BDMD

$1.77

QT Imaging Holdings Inc

NASDAQ:QTI

$6.98

1.00%

NeuroOne Medical Technologies Corp

Pulmonx Earnings Estimates, EPS & Revenue | NASDAQ:LUNG

Pulmonx (LUNG) is scheduled to report Q1 earnings on April 29, 2026. Analysts estimate EPS of $-0.33 and quarterly revenue of $20.29M.

In the most recent quarter (Q4), Pulmonx reported EPS of $-0.25, beating estimates of $-0.39 by 0.36%. Revenue came in at $22.60M, exceeding the estimate of $21.73M by 0.04%.

Pulmonx has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, Pulmonx has averaged an EPS surprise of 0.17% and a revenue surprise of 0.03%.

Earnings Date

Apr 29

EPS Estimate

$-0.330

Quarterly Revenue Estimate

$20.29M

Annual Revenue
(as of Dec 31)

$90.50M